Scienmag

DECEMBER 9, 2020

News from the Journal of Marketing Researchers from Temple University, Tsinghua University, and Fudan University published a new paper in the Journal of Marketing that explores the business impact of PPI on buyers’ purchase behaviors and sellers’ sales activities.

Sales 75

Sales Marketing Research Engineer 75

World of DTC Marketing

NOVEMBER 24, 2020

SUMMARY : In a 2019 Pew Research Center poll, more Americans said they consider made-up news a bigger problem than terrorism, illegal immigration, racism, and sexism. 2wo : Pharma websites are seen as a sales tool rather than a patient tool. And 68% said disinformation greatly impacts people’s confidence in government institutions.

Scientist 277

Scientist Pharma Companies Production Sales 277

Pharmaceutical Technology

MAY 16, 2023

The deal encompasses Vivotif and Vaxchora, both marketed vaccines for the prevention of typhoid fever and cholera respectively, and a Phase III vaccine candidate for the prevention of Chikungunya virus, which have now all been transferred to Bavarian Nordic. The news comes after a tricky opening quarter for Emergent.

Vaccination 130

Vaccination Vaccine Licensing Licensing 130

World of DTC Marketing

JULY 21, 2022

Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales. Despite the number of DTC conferences, there isn’t any one magic formula for successful DTC marketing. The MS market is a great example. DTC marketers seem to ignore this data. It’s not more T.V.

Marketing 266

Marketing Drugs Pharma Companies Doctors 266

pharmaphorum

OCTOBER 12, 2021

Sales were $20 million and $0.5 Gocovri could see its sales momentum rise following its approval for a second indication by the FDA earlier this year. per share subject to Gocovri meeting sales targets. per share subject to Gocovri meeting sales targets. million, respectively, in the second quarter of this year.

Sales 97

Sales Gene Therapy Production Marketing 97

pharmaphorum

DECEMBER 12, 2022

billion ($3.6bn) in annual sales from Tepezza (teprotumumab), a treatment for the painful autoimmune condition thyroid eye disease (TED). J&J soon pulled out, but the news resulted also in an increased market value of €20.9 Californian biotech Amgen’s own market value is circa €141.7 Under Rule 8.3(a)

Sales 105

Sales Marketing Medicine Production 105

World of DTC Marketing

APRIL 23, 2021

QUICK READ: The MedAd News Manny Awards were last night. There is still much to emphasis on doing things that deliver sales rather than helping patients. Just when you think you have broken through, pharma marketing, people rotate, leave, or get promoted, and the process is pushed back three or four steps.

Pharma Companies 188

Pharma Companies Doctors Doctor Marketing 188

pharmaphorum

JUNE 20, 2022

The rumour was first published in the Wall Street Journal, which suggests that a takeover is just one option on the table, along with a marketing deal that would bind the two companies together without the risk of antitrust issues holding up or blocking a merger. It says Merck has hesitation about whether a deal could make it through FTC.

Sales 105

Sales Marketing Drugs Licensing 105

pharmaphorum

JUNE 1, 2022

GlaxoSmithKline is due to complete the split from its consumer health decision – now renamed Haleon – next month, with a listing for the new company on the London Stock Exchange set for 18 July. A listing on the New York Stock Exchange will follow shortly, according to the pharma group.

Sales 105

Sales Vaccination Vaccine Branding 105

pharmaphorum

MARCH 3, 2022

DarioHealth has beefed up its sales and marketing channels as well as its range of digital health products thanks to a $30 million strategic alliance with drugmaker Sanofi. Erez Raphael.

Behavioural Health 91

Behavioural Health Sales Marketing Clinical Trials 91

World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. They relied so much on a new drug that they tried to market a product with bad science behind it. The pharma industry is a giant behemoth that needs new drugs to survive and grow.

Pharma Companies 210

Pharma Companies Marketing Drugs Production 210

XTalks

JULY 7, 2023

Earlier this week, the World Health Organization (WHO) released new guidelines that emphasized the critical role that marketers must play in safeguarding children’s health. The WHO underscored the need for tighter regulations to protect children from the adverse effects of food marketing.

Marketing 97

Marketing Production Regulation Branding 97

World of DTC Marketing

FEBRUARY 28, 2022

There isn’t one formula for all DTC marketing, but they all have in common that the number of online health seekers has increased over the last two years. That’s good news, but it’s also bad news. Then there is email marketing. So what’s the answer?

Branding 164

Branding Marketing Doctors Doctor 164

pharmaphorum

MARCH 15, 2022

In return, it will get a royalty on sales if the new version gets approved. That may not prove to be a good investment, given the news this week that bempeg failed a phase 3 trial in melanoma as a combination therapy with Bristol-Myers Squibb’s Opdivo (nivolumab).

Trials 97

Trials Sales Drug Delivery Antibody 97

BioTech 365

JANUARY 19, 2022

EQS-News: Zur Rose Group AG / Key word(s): Development of Sales 20.01.2022 / 07:00 Frauenfeld, 20 January 2022 Press release Zur Rose Group: steady growth in a volatile market environment – Revenue outlook for financial year 2021 achieved … Continue reading →

Marketing 40

Marketing Sales Development 40

pharmaphorum

NOVEMBER 2, 2022

GSK now expects sales to grow between 8% and 10% at constant exchange rates this year, up from its previous prediction of 6% to 8%, with an operating profit of 15%-17% versus 13%-15%. billion (around $8.9 billion) against consensus forecasts of around £7.3 Operating profit was up 18% to £2.6 May decision on RSV vaccine.

Vaccination 98

Vaccination Vaccine Sales Marketing 98

Scienmag

NOVEMBER 19, 2020

News from the Journal of Marketing Researchers from Temple University, Sichuan University, and Fudan University published a new paper in the Journal of Marketing that explores the growing use of AI to coach sales agents to determine if there are any caveats that inhibit the effective use of this technology.

Sales 49

Sales Marketing Research Engineer 49

World of DTC Marketing

FEBRUARY 2, 2022

Biogen will partner with Roche on the development, and potential sale of a promising cancer drug the Swiss pharma is advancing for several types of lymphoma, announcing Tuesday it’s exercised an option to share rights to the treatment. Putting it on the market will stress Medicare’s resources.”

FDA Approval 239

FDA Approval Drugs Doctors Doctor 239

pharmaphorum

OCTOBER 20, 2020

Huge demand for ventilators and patient monitors spurred third quarter sales for Royal Philips, the company announced. The Dutch health technology group reported sales of €4.98bn, a 10% year-over-year growth. Sales were down 3%, to €1.97bn compared to a 9% dip in Q2.

Sales 105

Sales Radiology Medicine Production 105

Scienmag

FEBRUARY 23, 2021

News from the Journal of Marketing Researchers from University of British Columbia published a new paper in the Journal of Marketing that examines whether and how the use of ‘ugly’ labeling for unattractive produce increases sales and profit margins.

Sales 40

Sales Marketing Research Production 40

pharmaphorum

MAY 27, 2021

The approval is good news for Myovant’s partner Pfizer too, as the big pharma agreed a $4.2 The two companies share marketing rights to relugolix products in North America, while Pfizer has exclusive rights elsewhere.

Hormones 98

Hormones Sales Marketing Drugs 98

Intouch Solutions

FEBRUARY 8, 2022

It’s not exactly news to say that COVID-19 has been a catalyst for monumental changes in the healthcare industry. So what does that mean, and what will it look like, especially as sales rep layoffs and let-gos continue, and physicians say they want more real-world data and a lot less selling ?

Sales 52

Sales Clinical Trials Clinical Trials Marketing 52

Intouch Solutions

MARCH 2, 2023

Note: Endpoints News Premium requires a subscription.) ChatGPT and Generative AI Land in Pharma Marketing With Sense of Awe — and Plenty of Caution – Endpoints News “What pharma companies and companies like us need to do to make [AI] work is to ‘pharmatize’ it,” Faruk told Senior Editor Beth Snyder Bulik.

Marketing 52

Marketing Life Science Pharma Companies Sales 52

pharmaphorum

JANUARY 29, 2021

The post-marketing safety study showed that Xeljanz (tofacitinib) – used to treat rheumatoid arthritis (RA) – was associated with a higher rate of heart attacks and cancer than a TNF inhibitor in patients aged over 50 with underlying cardiovascular risk factors. Now, a study designed to prove its safety has achieved the opposite.

Trials 135

Trials Marketing Sales Drugs 135

pharmaphorum

FEBRUARY 21, 2022

It’s a key moment for the two companies, as expansion into HER2-low breast cancer has been held up as a key requirement for Enhertu (trastuzumab deruxtecan) if it is to achieve its multibillion-dollar sales expectations. billion to Daiichi Sankyo if all the ADC’s development and sales objectives are achieved.

Trials 132

Trials Sales Hormones Drugs 132

Pharma Marketing Network

JULY 13, 2023

When it comes to marketing your pharma business on Facebook, you may be wondering whether you should boost a post or create an ad. Placement: Your boosted post can appear in the News Feed, in the right column, or in Messenger. Your ad can appear in a variety of places, such as the News Feed, the Audience Network, or Instagram.

Marketing 98

Marketing Branding Sales 98

pharmaphorum

FEBRUARY 22, 2021

AZ’s share price ticked downwards after the announcement that it will stop marketing Imfinzi, a PD-L1 class immunotherapy, for previously treated adult patients with advanced or metastatic bladder cancer. The news will come as a blow for AZ, where Imfinzi has been an important component of the company’s cancer portfolio.

Trials 52

Trials Sales Marketing Drugs 52

World of DTC Marketing

AUGUST 10, 2021

The bad news is that they are often left to determine what health information is accurate and which is not. There is a HUGE opportunity for pharma companies to help sort through all the misinformation and talk to patients as people, not sales targets.

Production 180

Production Pharma Companies Doctors Doctor 180

pharmaphorum

DECEMBER 10, 2021

Already scrambling to refile its obeticholic acid (OCA) drug for non-alcoholic steatohepatitis (NASH) after the FDA rejected it last year, Intercept Pharma was hoping for more luck in Europe, but has now withdrawn its EU marketing application. Shares in Intercept slipped around 15% after it announced the news.

Drugs 98

Drugs Sales Marketing Packaging 98

World of DTC Marketing

JANUARY 24, 2022

Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? VCs invest money in biotech because they see a potential windfall via a profitable acquisition or sale, but when the FDA weighs in with delays, VCs can be ruthless. not necessarily. Only about $2.2

Life Science 225

Life Science Drugs Genetic Disease Development 225

pharmaphorum

DECEMBER 15, 2022

Stefan Woxström is the new senior vice president for Europe and Canada at AstraZeneca, moving over from the company’s Japanese division to take over from Iskra Reic , who will now serve as EVP of vaccines and immune therapies. New CEO in at Angelini Pharma. More CEO shakeups.

Sales 52

Sales In-Vitro Antibody Drug Delivery 52

pharmaphorum

AUGUST 7, 2020

Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales. Find out more in our roundup of the biggest R&D, market access and digital stories from the past week. Meanwhile, Bayer’s Q2 sales were down 2.5% to just over €10 billion, with pharma falling 8.8%

Sales 105

Sales Antibody Vaccination Vaccine 105

Intouch Solutions

MARCH 2, 2022

My second favorite thing about pharmaceutical marketing is the wonderful customer complexity (the first, of course, is that we can use our marketing superpowers for good not evil). The labyrinth of customers, each with different and often contradictory needs, makes Rx marketing a game of three-dimensional chess.

Marketing 52

Marketing Branding Sales Pharmacy 52

pharmaphorum

JANUARY 9, 2023

He continued: “Amryt has steadily brought innovative products to new markets and, by adding them to the Chiesi portfolio, we hope to make them available to even more patients who may require them.”. Additionally, its top-selling drug, Myalept or Myalepta, had third-quarter sales of $37.9m.

Sales 98

Sales Medicine Marketing Development 98

World of DTC Marketing

MAY 16, 2022

The approval for tirzepatide—which Lilly will market under the brand name Mounjaro—isn’t for weight loss but Type 2 diabetes. Another said, as the news about weight loss circulates, he expects a lot of patients to ask for the product. Sales of Mounjaro could approach $14 billion annually by 2030. A matter of trust?

Drugs 218

Drugs Pharma Companies Clinical Trials Clinical Trials 218

pharmaphorum

NOVEMBER 18, 2020

The decision means that with two CGRP antibodies now cleared for migraine prevention, the first drug in the class to be approved in Europe – Novartis’ Aimovig (erenumab) – has fallen further behind its rivals in getting access to the UK market.

Sales 96

Sales Botox Antibody Drugs 96

pharmaphorum

JANUARY 17, 2022

In recent years it has successfully integrated the Novartis consumer health portfolio and the Pfizer portfolio, which resulted in annual sales of £9.6 However, amid news of the proposals, GSK’s share price was up almost 5% on Monday morning, while Unilever shares fell by as much as 7.3% billion in 2021. in London.

Marketing 118

Marketing Sales 118